Last updated on August 2019

Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia

Brief description of study

The objective of the study is to investigate the efficacy, safety and pharmacokinetics of four different doses of BI 425809 once daily compared to placebo given for 12 weeks in patients with schizophrenia on stable antipsychotic treatment.

Clinical Study Identifier: NCT02832037

Find a site near you

Start Over

CNRI - Los Angeles

Pico Rivera, CA United States
  Connect »